President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through ...

In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal to cap insulin ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell an affordable version of the drug to residents, Gov. Gavin Newsom announced ...

Sprouts employs approximately 35,000 associates and operates more than 450 stores in 24 states nationwide. The Phoenix-based ...

In a challenge to the pharmaceutical industry, Gov. Gavin Newsom on Thursday announced a plan to offer $11 insulin pens through the state's prescription program, far below market cost. Beginning Jan.

Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However, access ...

The specialty grocer, which spends millions each year on insulin for employees, accused the companies of profiting from ...